Bristol-Myers Squibb and Celgene announced the first merger deal of 2019 in the health care sector. Photo: Handout

Global health care deals expected to top US$400 billion this year, says law firm Baker McKenzie

  • Deal flow is expected to rebound after dropping 5 per cent in 2018
  • Political uncertainty, new regulations weighed on transactions last year
Topic |   Mergers & Acquisitions

TOP PICKS

Bristol-Myers Squibb and Celgene announced the first merger deal of 2019 in the health care sector. Photo: Handout
READ FULL ARTICLE